HealthWarehouse.com, Inc.
HEWA · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.19 | -0.04 | -0.16 | 0.06 |
| FCF Yield | 12.81% | -6.22% | -11.55% | 4.04% |
| EV / EBITDA | 21.05 | -7.17 | -21.18 | -34.44 |
| Quality | ||||
| ROIC | 47.86% | 128.07% | -7,426.89% | -146.73% |
| Gross Margin | 40.73% | 60.02% | 65.82% | 68.96% |
| Cash Conversion Ratio | -2.12 | 0.09 | 0.66 | -0.70 |
| Growth | ||||
| Revenue 3-Year CAGR | 22.82% | 7.91% | 1.84% | 0.81% |
| Free Cash Flow Growth | 219.32% | 58.34% | -462.61% | 30.26% |
| Safety | ||||
| Net Debt / EBITDA | 8.01 | -1.19 | -3.58 | 0.14 |
| Interest Coverage | -0.39 | -10.68 | -4.78 | -2.06 |
| Efficiency | ||||
| Inventory Turnover | 23.67 | 15.93 | 12.34 | 17.82 |
| Cash Conversion Cycle | 2.27 | -6.71 | -0.92 | -25.07 |